Chester County News and Community Website
West Pharmaceutical Services, Inc. (NYSE: WST), headquartered in Exton, PA, is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products.
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has introduced a new nested format for its Daikyo PLASCAP® Ready-to-Use Validated (RUV) closures, available in multiple configurations. This advancement, revealed at …
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has announced the recent election of Janet Haugen to its Board of Directors. With her appointment, the board now consists of 12 …
Janet Haugen Joins West Pharmaceutical Services Board of Directors Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has released its financial results for the third quarter of 2024, alongside an updated financial outlook for the year. The company …
West Pharmaceutical Services Reports Solid Third-Quarter 2024 Results and Raises Guidance Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has been recognized with the prestigious Heart of Pharma Award at the 2024 CPHI Awards. This accolade, awarded during the opening night …
West Pharmaceutical Services Honored with Heart of Pharma Award for Cancer Partnership Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) reported its second-quarter 2024 financial results, revealing a significant drop in net sales and adjusted earnings per share (EPS). The company …
West Pharmaceutical Services Downscales 2024 Financial Outlook Amid Customer Destocking Challenges Read More
EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) introduced its new Daikyo Crystal Zenith® (CZ) Nested Vials in Tub at the International Society for Cell and Gene Therapy (ISCT) …
West Pharmaceutical Unveils Advanced Packaging for Gene Therapies Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) publicized its Q1 2024 financial results, revealing a 3.0% sales slump compared to last year. Both net sales, totaling $695.4 million, …
West Pharmaceutical Services Posts Q1 2024 Financial Results, Updates Full-Year Guidance Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST), a leading provider of injectable solutions and services, recently announced a second-quarter 2024 dividend of $0.20 per share. The Exton, Pennsylvania-based …
West Pharmaceutical Services Announces Second-Quarter Dividend of $0.20 Per Share Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) has recently published its fourth-quarter and full-year 2023 financial results and issued its full-year 2024 financial guidance. The figures demonstrate clear …
West Pharmaceutical Reveals Favorable 2023 Financial Performance, Unveils 2024 Outlook Read More EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in solutions for injectable drug administration, has been recognized as one of America’s Greatest Workplaces for Diversity 2024 …
West Pharmaceutical Services: A Beacon of Diversity in the Industry Read More